Download PDF
Am J Perinatol 2019; 36(02): 111-117
DOI: 10.1055/s-0038-1668547
SMFM Fellowship Series Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cervical Cerclage versus Vaginal Progesterone for Management of Short Cervix in Low-Risk Women

Amber M. Wood
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina
,
Sarah K. Dotters-Katz
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina
,
Brenna L. Hughes
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina
› Author Affiliations Funding None.
Further Information

Publication History

21 March 2018

11 July 2018

Publication Date:
15 August 2018 (online)

    Permissions and Reprints

Abstract

Objective To evaluate the risk of preterm birth in low-risk women with cervical length (CL) ≤25 mm on transvaginal ultrasound (TVUS) managed with vaginal progesterone (VagP) therapy versus cerclage.

Study Design This is a retrospective cohort of women with no prior history of preterm birth or cervical insufficiency and CL ≤ 25 mm on TVUS, managed with either VagP therapy alone or cerclage (with or without VagP). The primary outcome was rate of preterm delivery < 37 weeks gestational age (GA). Secondary outcomes included delivery at ≤ 32 or ≤ 28 weeks GA, premature preterm rupture of membranes, pregnancy latency, GA at delivery, and composite neonatal outcome.

Results Women undergoing cerclage placement (n = 31) were older and had an earlier GA at the time of diagnosis of short cervix compared with women receiving VagP (n = 62). Delivery at < 37 weeks occurred in 21/62 (33.9%) in the VagP group and 14/31 (45.2%) in the cerclage group (adjusted odds ratio: 1.72, 95% confidence interval: 0.52, 5.66). There were no differences in secondary outcomes.

Conclusion Cerclage compared with VagP therapy did not decrease risk of preterm birth in women with CL ≤ 25 mm. Further research is needed to determine optimal management in such women given a residual 40% risk of preterm birth despite optimal therapy.

Keywords

cervical cerclage - preterm birth - short cervix - vaginal progesterone

Condensation

In low-risk women with CL ≤ 25 mm on TVUS, cerclage does not decrease the risk of preterm birth compared with VagP.


 

  • References

  • 1 Matthews TJ, MacDorman MF, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. Natl Vital Stat Rep 2015; 64 (09) 1-30
    PubMedGoogle Scholar
  • 2 Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371 (9606): 75-84
    CrossrefPubMedGoogle Scholar
  • 3 Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2016. Natl Vital Stat Rep 2018; 67 (01) 1-55
    PubMedGoogle Scholar
  • 4 Iams JD, Goldenberg RL, Meis PJ. , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334 (09) 567-572
    CrossrefPubMedGoogle Scholar
  • 5 Hassan SS, Romero R, Vidyadhari D. , et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38 (01) 18-31
    PubMedGoogle Scholar
  • 6 Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol 2008; 31 (05) 579-587
    CrossrefPubMedGoogle Scholar
  • 7 Hibbard JU, Tart M, Moawad AH. Cervical length at 16-22 weeks' gestation and risk for preterm delivery. Obstet Gynecol 2000; 96 (06) 972-978
    PubMedGoogle Scholar
  • 8 Berghella V, Roman A, Daskalakis C, Ness A, Baxter JK. Gestational age at cervical length measurement and incidence of preterm birth. Obstet Gynecol 2007; 110 (2 Pt 1): 311-317
    CrossrefPubMedGoogle Scholar
  • 9 Owen J, Hankins G, Iams JD. , et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009; 201 (04) 375.e1-375.e8
    CrossrefPubMedGoogle Scholar
  • 10 Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 2011; 117 (03) 663-671
    CrossrefPubMedGoogle Scholar
  • 11 Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106 (01) 181-189
    CrossrefPubMedGoogle Scholar
  • 12 Incerti M, Ghidini A, Locatelli A, Poggi SH, Pezzullo JC. Cervical length < or = 25 mm in low-risk women: a case control study of cerclage with rest vs rest alone. Am J Obstet Gynecol 2007; 197 (03) 315.e1-315.e4
    CrossrefPubMedGoogle Scholar
  • 13 Berghella V, Keeler SM, To MS, Althuisius SM, Rust OA. Effectiveness of cerclage according to severity of cervical length shortening: a meta-analysis. Ultrasound Obstet Gynecol 2010; 35 (04) 468-473
    CrossrefPubMedGoogle Scholar
  • 14 Hassan SS, Romero R, Maymon E. , et al. Does cervical cerclage prevent preterm delivery in patients with a short cervix?. Am J Obstet Gynecol 2001; 184 (07) 1325-1329
    CrossrefPubMedGoogle Scholar
  • 15 Parrish MR, Salpekar M, Lee G. Pregnancy outcomes after cerclage placement in nulliparous women with a short cervix on transvaginal ultrasonography. J Matern Fetal Neonatal Med 2016; 29 (20) 3281-3285
    PubMedGoogle Scholar
  • 16 Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. ; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357 (05) 462-469
    CrossrefPubMedGoogle Scholar
  • 17 Romero R, Nicolaides KH, Conde-Agudelo A. , et al. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol 2016; 48 (03) 308-317
    CrossrefPubMedGoogle Scholar
  • 18 Romero R, Nicolaides K, Conde-Agudelo A. , et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206 (02) 124.e1-124.e19
    CrossrefPubMedGoogle Scholar
  • 19 ACOG. Methods for Estimating the Due Date. Committee opinion No. 700. Obstet Gynecol 2017; 129: e150-e54
    CrossrefPubMedGoogle Scholar
  • 20 Romero R, Conde-Agudelo A, Da Fonseca E. , et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol 2018; 218 (02) 161-180
    CrossrefPubMedGoogle Scholar
  • 21 To MS, Alfirevic Z, Heath VC. , et al; Fetal Medicine Foundation Second Trimester Screening Group. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004; 363 (9424): 1849-1853
    CrossrefPubMedGoogle Scholar
  • 22 ACOG. Prediction and prevention of preterm birth. Committee opinion No. 130. Obstet Gynecol 2012; 120: 964-973
    CrossrefPubMedGoogle Scholar
  • 23 ACOG. Cerclage for the management of cervical insufficiency. Practice bulletin No. 142. Obstet Gynecol 2014; 123: 372-379
    CrossrefPubMedGoogle Scholar